星凱控股(01166.HK)中期盈轉虧至1091.2萬港元
格隆匯2月27日丨星凱控股(01166.HK)公佈中期業績,截至2022年12月31日止6個月,公司營業額為1.95億港元,同比減少27.45%;公司股東應占期內虧損為1091.2萬港元,去年同期盈利4674.1萬港元;基本每股虧損為0.46港仙。
按業務劃分而言,電線及電纜營業額約為1.10億港元,較去年同期減少35.2%,佔集團總營業額56.5%;銅杆業務營業額約為7871.8萬港元,較去年同期減少13.9%,佔集團總營業額40.5%;收租業務營業額約為592.2萬港元,較去年同期減少16.0%,佔集團總營業額3.0%;其他業務於回顧期內沒有業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.